EU: BTG Tries Again With Voraxaze After 15 Years

 
• By Neena Brizmohun

Voraxaze, vosoritide and TransCon hGH are among the latest products that have been submitted to the European Medicines Agency for review for potential pan-EU marketing approval.

EU - capsule
New drug marketing applications have been filed in the EU • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards